Health-Related Quality of Life during COVID-19 Pandemic: Assessing Impacts of Job Loss and Financial Support Programs in Japan.

Allowance EQ-5D Euro-QoL SARS-CoV-2 Socioeconomic status Subsidy

Journal

Applied research in quality of life
ISSN: 1871-2584
Titre abrégé: Appl Res Qual Life
Pays: Netherlands
ID NLM: 101313787

Informations de publication

Date de publication:
2022
Historique:
received: 02 12 2020
accepted: 05 01 2021
pubmed: 9 2 2021
medline: 9 2 2021
entrez: 8 2 2021
Statut: ppublish

Résumé

This cross-sectional study examined the association between job loss during the coronavirus disease 2019 (COVID-19) pandemic and health-related quality of life (HRQOL) in the Japanese working population and whether universal financial support program has a protective influence on the HRQOL. Two self-reported internet surveys were used to determine job loss during the pandemic: one was conducted between February and March 2020, just before the COVID-19 emergency declaration by the Japanese government (April 2020), and the other was conducted between August and September 2020. For the dependent variable, we used the EQ-5D-5L utility score (QOL utility score), which was assessed between August and September 2020. The independent variables were job loss after the state of emergency was declared and two types of government financial support (either universal support or support targeting child-raising households). The Tobit regression model was applied, adjusting for covariates. Job loss during the pandemic was negatively associated with the QOL utility score in the fully adjusted model; the coefficient (95% confidence interval [CI]) for job loss during the pandemic was -0.07 (-0.11 to -0.03). For the government financial support variables, the universal financial support program was associated with a better QOL utility score of the coefficient (95% CI), 0.05 (0.03 to 0.08). Job loss during the COVID-19 pandemic is negatively associated with HRQOL, while universal financial support is positively associated with HRQOL. Our study results imply that universal financial support during the COVID-19 era has a protective influence on an individual's HRQOL. The online version contains supplementary material available at 10.1007/s11482-021-09918-6.

Identifiants

pubmed: 33552309
doi: 10.1007/s11482-021-09918-6
pii: 9918
pmc: PMC7846494
doi:

Types de publication

Journal Article

Langues

eng

Pagination

541-557

Informations de copyright

© The International Society for Quality-of-Life Studies (ISQOLS) and Springer Nature B.V. 2021.

Déclaration de conflit d'intérêts

Competing InterestsNone

Références

Tob Control. 2018 Jul;27(e1):e25-e33
pubmed: 29248896
J Affect Disord. 2020 Dec 1;277:55-64
pubmed: 32799105
Int J Soc Psychiatry. 2021 Feb;67(1):35-45
pubmed: 32615833
Ann Intern Med. 2020 Nov 3;173(9):767-770
pubmed: 32598162
BMJ. 2020 Oct 8;371:m3687
pubmed: 33032997
Bioinformatics. 2012 Jan 1;28(1):112-8
pubmed: 22039212
Eur J Health Econ. 2019 Mar;20(2):205-216
pubmed: 29445941
Depress Anxiety. 2020 Oct;37(10):954-956
pubmed: 32667081
Value Health. 2002 Jul-Aug;5(4):329-37
pubmed: 12102695
MMWR Morb Mortal Wkly Rep. 2020 Sep 11;69(36):1250-1257
pubmed: 32915166
Int J Soc Psychiatry. 2020 Sep;66(6):525-527
pubmed: 32349580
Lancet Infect Dis. 2020 Oct;20(10):1151-1160
pubmed: 32559451
J Vocat Behav. 2020 Jun;119:103434
pubmed: 32390655
BMC Public Health. 2019 Apr 29;19(1):457
pubmed: 31035994
Lancet Psychiatry. 2020 May;7(5):389-390
pubmed: 32353269
Int J Epidemiol. 2018 Feb 1;47(1):58-68
pubmed: 29024999
Qual Life Res. 2000;9(8):901-10
pubmed: 11284209
Curr Epidemiol Rep. 2016 Mar;3(1):81-91
pubmed: 27239427
J Health Econ. 2012 Sep;31(5):744-51
pubmed: 22898452
Gac Sanit. 2020 May - Jun;34(3):245-252
pubmed: 32005597
J Epidemiol. 2019 Nov 5;29(11):444-450
pubmed: 30318495
BMJ. 2020 Jul 15;370:m2743
pubmed: 32669358
Psychosom Med. 2021 May 1;83(4):328-337
pubmed: 33009276
Health Qual Life Outcomes. 2018 Nov 8;16(1):210
pubmed: 30409137
Environ Health Prev Med. 2011 Jan;16(1):25-35
pubmed: 21432214

Auteurs

Takaaki Ikeda (T)

Department of Health Policy Science, Graduate School of Medical Science, Yamagata University, Yamagata, Japan.
Department of International and Community Oral Health, Tohoku University Graduate School of Dentistry, Miyagi, Japan.

Ataru Igarashi (A)

Yokohama City University School of Medicine, Kanagawa, Japan.

Satomi Odani (S)

Cancer Control Center, Osaka International Cancer Institute, Osaka, Japan.

Masayasu Murakami (M)

Department of Health Policy Science, Graduate School of Medical Science, Yamagata University, Yamagata, Japan.

Takahiro Tabuchi (T)

Cancer Control Center, Osaka International Cancer Institute, Osaka, Japan.

Classifications MeSH